Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
3.250
-0.270 (-7.67%)
At close: Aug 5, 2026, 4:00 PM EDT
3.260
+0.010 (0.31%)
Pre-market: Aug 6, 2026, 8:18 AM EDT

Aethlon Medical Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
----0.570.29
Revenue Growth
----95.21%-55.37%
Gross Profit
----0.570.29
Operating Income
-7.29-7.29-9.34-12.64-11.9-10.42
Net Income
-7.15-7.15-13.39-12.21-12.03-10.42
Earnings Per Share
-53.05-53.05-428.85---
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
5.035.035.55.4414.5317.07
Total Debt
0.340.340.650.941.210.73
Net Cash (Debt)
4.694.694.854.513.3216.34
Net Cash Growth
-3.33%-3.33%7.77%-66.21%-18.47%66.44%
Net Cash Per Share
34.7934.79155.41---

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-7-7-7.65-10.13-10.51-9.77
Capital Expenditures
-0-0--0.25-0.94-0.35
Free Cash Flow
-7-7-7.65-10.38-11.45-10.12
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
----100.00%100.00%
Operating Margin
-----2072.05%-3542.53%
Pretax Margin
-----2121.55%-3542.53%
Profit Margin
-----2121.55%-3542.53%
FCF Margin
-----1993.62%-3439.01%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-4.574.574.574.57-
PS Ratio
----15.2176.51